Objectives-The aim of this study was to quantify the rate of incidental findings identified on elective research echocardiography performed on neonates younger than 29 weeks' gestation.
T argeted neonatal echocardiography is performed for a wide variety of indications, including assessment of myocardial function, evaluation of a patent ductus arteriosus (PDA), and diagnosis of pulmonary hypertension (PH). In recent years, targeted neonatal echocardiography has been increasingly used to provide real-time data on the cardiovascular status of neonatal patients to identify hemodynamic compromise, aid in clinical decision making, and monitor treatment responses. With such growing use of targeted neonatal echocardiography, the discovery of incidental findings is not uncommon. Such incidental findings can include umbilical catheter complications such as malpositioned umbilical venous catheters and liver hematomas secondary to their use and undiagnosed or unsuspected congenital heart disease (CHD), which has a higher prevalence in the preterm population than previously thought. 1, 2 With the rising use of targeted neonatal echocardiography as both a diagnostic and research tool, the concomitant detection of unexpected findings is also increasingly frequent. In particular, the rate of malpositioned umbilical venous catheters that are placed over the first 24 hours of age, the resultant potential complications of malpositioning, the incidence of undiagnosed CHD (other than a PDA and a patent foramen ovale), and their potential influence of those incidental findings on important outcome measures warrants further study.
In our institution, routine elective echocardiographic examinations for research purposes were performed over a 3-year period in neonates younger than 29 weeks' gestation within the first 24 hours of age. We hypothesized that the rate of incidental pathologic findings in this cohort would be high. The aim of this study was to quantify the rate of incidental findings identified on elective research echocardiography performed on neonates younger than 29 weeks' gestation.
Materials and Methods
We conducted a retrospective review of echocardiographic examinations performed within the first 24 hours of age on neonates younger than 29 weeks' gestation in the Rotunda Hospital over a 3-year period for research purposes (July 2013-June 2016). The echocardiographic examinations were performed to provide reference data and evaluate maturational changes of cardiac performance, to assess the impact of a PDA on the circulation, and to provide reproducibility data for those measurements. [3] [4] [5] [6] None of the examinations were performed for clinical indications or on the request of the clinician caring for the neonate. All included neonates underwent a routine fetal ultrasonographic anomaly scan between 18 and 22 weeks' gestation. Neonates with any identified anomalies during the antenatal period did not undergo research echocardiography because of their ineligibility. All included preterm neonates were in a clinically stable condition, were receiving routine intensive care, and were not in receipt of inotropes or inhaled nitric oxide at the time of the assessment. Neonates who underwent echocardiography for clinical purposes were excluded from this analysis. Ethical approval was sought and granted from the Rotunda Hospital Clinical Audit Working Group.
We collected relevant antenatal and delivery-related variables on all neonates, including gestation, birth weight, sex, mode of delivery, and condition at birth (cord pH and Apgar score). Important outcome measures were also collected, including intraventricular hemorrhage, time to full feeds, chronic lung disease (defined as the need for oxygen at 36 weeks postmenstrual age), death before discharge, and duration of the hospital stay.
Echocardiographic Examinations
All echocardiographic examinations were performed with Vivid echocardiography system (Vivid i and S6; GE Healthcare, Milwaukee, WI) by 1 of 2 clinical research fellows (A.T.J. or C.R.B.) who were fully trained in structural and functional studies under the supervision of an expert neonatologist (A.E.-K.) and a pediatric cardiologist (O.F.). A full sequential assessment of function and structure was performed on all neonates in accordance with recently established guidelines. 7, 8 All neonates were in a quiet resting state during the examination. All echocardiograms were obtained after the initial stabilization of the neonate (including intubation and surfactant administration, if warranted) and after the insertion and securement of all central lines, including umbilical venous catheters. The echocardiographic examinations were all performed after the clinical team deemed the umbilical venous catheters to be in a good position on anteroposterior and lateral radiographs and were sanctioned for use. The echocardiograms were retrospectively reviewed by an investigator who was blinded to the clinical characteristics of the neonate (A.S.). The following specific abnormalities and findings were sought: (1) a malpositioned umbilical venous catheter situated in the heart (right and left atria) or within the liver proximal to the inferior vena cava and right atrial junction; (2) asymptomatic complications resulting from malpositioning, including intracardiac or intrahepatic clots, liver hematomas, and pericardial effusions; (3) CHD other than a PDA or a patent foramen ovale (for the purposes of this review, atrial septal defects were only diagnosed if they were >4 mm in diameter and present by hospital discharge); and (4) severe PH with suprasystemic pulmonary pressures, defined as a pure right-to-left shunt across the PDA without evidence of CHD, intraventricular septal bowing into the left ventricle, or the presence of a tricuspid regurgitant jet estimating the right ventricular pressure to be greater than the systemic systolic pressure.
Statistical Analysis Continuous variables were tested for normality by the Shapiro-Wilk test and presented as means 6 standard deviations or medians (interquartile ranges). Categorical variables were presented as proportions. Two group analyses of continuous variables were conducted by an independent Student t test or the Mann-Whitney U test as appropriate. Proportions were compared by a v 2 or Fisher exact test as appropriate. Logistic regression was used to assess the independent effect of incidental findings on the combined outcome of chronic lung disease or death before discharge while adjusting for important variables identified from univariate analysis. We used SPSS version 23 software (IBM Corporation, Armonk, NY) to conduct the analysis, and P < .05 was considered significant.
Results
Echocardiograms from 168 neonates were identified as potential research scans over the 3-year study period. Seventeen echocardiograms were later recognized as obtained on clinical grounds, and in 6 neonates, there was no echocardiogram obtained within the first 24 hours. A total of 145 echocardiograms obtained at a median (interquartile range) of 10 (7-13) hours were included for review. The neonate cohort had a gestational age and birth weight of 26.9 (25.7-28.0) weeks and 940 (750-1130) g, respectively. Table 1 illustrates clinical demographics, antenatal and delivery details, and important outcomes in neonates with and without unexpected findings.
Forty-three neonates (30%) had a total of 54 unexpected findings (37%). Most of the incidental findings comprised malpositioned umbilical venous catheters in 87 neonates (60%) for whom central umbilical access was used. The most common misplacement was in the left atrium (Table 2 and Figure 1 ). The rate of CHD was 10%, the most common being an atrial septal defect. One neonate (27 weeks' gestation, twin) had an incidental finding of total anomalous pulmonary venous drainage, and another (28 weeks' gestation, triplet) had transposition of the great arteries; both had acceptable saturations at the time of the scan (>90%), with no clinical suspicion of CHD either antenatally or after the initial routine investigations, which included radiographs. Both of those neonates died before hospital discharge. Data are presented as median (interquartile range), mean 6 SD, and number (percent). CLD indicates chronic lung disease; IVH, intraventricular hemorrhage; PPROM, preterm premature rupture of membranes; and SGA, small for gestational age.
Four incidental liver hematomas were identified and were associated with malpositioned umbilical venous catheters (Figure 2) . The identification of the liver hematomas prompted the removal of the catheters found adjacent to the lesions. All 4 neonates had full recovery with resolution of the hematomas before discharge. The remainder of the findings included pericardial effusions (which subsequently resolved spontaneously) and unexpected PH, with suprasystemic pulmonary pressures ( Table 2) . Two of the neonates identified as having PH subsequently received inhaled nitric oxide for an increasing oxygen requirement with good recovery.
The presence of unexpected findings on targeted neonatal echocardiography was independently associated with a combined outcome of chronic lung disease or death when controlling for gestation, sex, 5-minute Apgar score, chorioamnionitis, preeclampsia, and the use of antenatal steroids (adjusted odds ratio, 4.3 [95% confidence interval, 1.5-12.4]; P 5 .007).
Discussion
This study identified the presence of a relatively high rate of asymptomatic abnormalities and incidental findings on screening echocardiograms. Those included malpositioned umbilical venous catheters and their complications, cyanotic and acyanotic CHD, severe PH, and pericardial effusions. Interestingly, malpositioned umbilical venous catheters were more likely to be placed in the left, rather than the right, atrium. Neonates with unexpected findings had an earlier gestation and lower birth weight, required a longer time to attain full enteral feeds, had a longer hospital admission, and had an increased incidence of CLD and death before discharge.
Echocardiography has been used since the 1980s to examine umbilical vascular catheter positions.
9,10 Ensuring correct umbilical catheter placement is critical, as potential complications of an erroneous position include intracardiac thrombosis (Figure 3) , endocarditis, arrhythmias, myocardial perforation, pericardial effusion, low cardiac output, and liver hematomas. [11] [12] [13] [14] [15] Several studies have demonstrated that ultrasonography and echocardiography are superior to radiography for localizing the umbilical catheter tip. 9, 11, [16] [17] [18] [19] [20] [21] Ades et al 11 Figure 1 . Umbilical venous catheter tip (arrows) situated in the left atrium on both the short-axis parasternal and apical 4-chamber views. Unless stated, the denominator for the values is 145.
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reported that echocardiography showed that umbilical venous catheters were correctly located at the right atrial-inferior vena cava junction in only 23% of the patients in their cohort; Pulickal et al 17 reported that 9 patients (27%) in their study required umbilical venous catheter repositioning when "targeted neonatal echocardiography revealed suboptimal tip position despite optimal position on chest radiography." Other studies examined the use of targeted neonatal echocardiography for the identification of a number of the aforementioned complications from umbilical catheters: for example, Abiramalatha et al 13 used targeted neonatal echocardiography to diagnose liver hematomas and left atrial thrombi.
Our study resonates with other work highlighting the limitations of abdominal and chest radiographs to confirm the umbilical venous catheter position. 11, 13, 21, 22 All the scans in our study were performed after the completion of all the necessary radiographs needed to determine umbilical venous catheter tip placement, which further highlights the potential difficulty of solely relying on radiographs to determine the umbilical venous catheter position. The margin of error for correct placement of an umbilical venous catheter in a preterm neonate is in the order of millimeters, and the catheter location may potentially shift from an adequate to an inadequate position with diaphragmatic movement during inspiration and expiration. Radiographs can only provide a static, snapshot representation of umbilical venous catheter placement during the dynamic process of respiration. Targeted neonatal echocardiography has the distinct advantage of providing real-time visualization of this 
active process and direct localization of the catheter with respect to its surrounding structures. In our cohort, 4 neonates (17%) were found to have unexpected liver hematomas on screening targeted neonatal echocardiography secondary to umbilical venous catheter insertion. This finding suggests that umbilical venous catheterrelated morbidity is likely underestimated in the current literature. Interestingly, the deepest catheters were located in the left, rather than the right, atrium, which may have reflected remnant fetal channels directing blood flow from the right atrium-inferior vena cava junction (and hence the catheter path) preferentially to the left atrium. This finding further highlights the importance of avoiding the placement of deep umbilical venous catheters, as they can potentially abrade the interatrial septal wall, thereby promoting clot formation.
Congenital heart disease occurs in 6 to 10 neonates per 1000 live births. 23 The rate of unsuspected CHD in our cohort of neonates younger than 29 weeks' gestation was 10%. Although the most frequent CHD identified was an atrial septal defect, 2 neonates were found to have major cyanotic heart disease: 1 with total anomalous pulmonary venous drainage and another with transposition of the great arteries. It is unlikely that our detection of atrial septal defects in this cohort would have resulted in a substantial change in management in the long term. All those neonates had a persistent shunt across the interatrial septum on discharge and were referred to the pediatric cardiologist for further followup. None of those defects warranted device or surgical occlusion to date. However, the detection of the 2 major cyanotic lesions occurred without a clinical suspicion. Both neonates underwent routine radiography and saturation monitoring before the echocardiogram and were not deemed to have anything outside the expected range for a premature neonate. These factors highlight the challenges of detecting cyanotic CHD in premature neonates during the early neonatal period, as the symptoms can be potentially masked by respiratory distress syndrome.
A recent study by Chu et al 2 found that premature neonates had a significantly higher birth prevalence of severe CHD compared to term neonates (7.4 per 1000 very/premature births versus 1.5 per 1000 term births; P < 0.01). Their results were consistent with a 2012 European study, which found that children with CHD (atrial septal defect and PDA) were twice as likely to be born prematurely (<37 weeks) or very/extremely prematurely (<32 weeks) than children without CHD. 24 Additionally, Chu et al 2 reported that the birth prevalence of severe defects was markedly higher for neonates born more prematurely: 8.8 at 35 to 36 weeks compared to 6.7 at 31 to 32 weeks per 1000 birth hospitalizations (P 5 .05), and greater prematurity was also associated with higher mortality, with very/extremely premature neonates who had severe CHD at a 7.5-fold increased adjusted odds ratio of death compared to those without CHD. Other unexpected findings identified in our study were 5 (3%) neonates with PH and 3 (2%) with pericardial effusions. The pericardial effusions self-resolved, and the impact of identifying subclinical PH in this cohort was questionable and could not be examined because of the relatively small number of cases.
The statistical analysis determined that unexpected findings on targeted neonatal echocardiography were independently associated with a combined outcome of chronic lung disease and death when controlling for other significant variables. Such data emphasize the idea that these incidental findings are substantial risk factors for morbidity and mortality in premature neonates and highlight the importance of early identification to instigate appropriate management and guide treatment decisions.
In conclusion, our study illustrates the high frequency at which unexpected asymptomatic conditions may be diagnosed on screening echocardiograms in preterm neonates younger than 29 weeks' gestation. The largest potential benefit appears to be in the identification of malpositioned umbilical venous catheters, thereby leading to the correction of their position and potential avoidance of catheter-related complications. Targeted neonatal echocardiography can also be potentially used to guide catheter tip placement to negate the need for repeated chest radiographs and minimize exposure to radiation. Therefore, routine targeted neonatal echocardiographic screening of preterm neonates may be warranted to identify the substantial likelihood of incidental findings, facilitate prompt medical management, minimize morbidity, and ameliorate patient outcomes. However, it is important to emphasize that personnel undertaking this screening must be fully trained and competent in performing a complete functional and anatomic echocardiographic examination in accordance with the most recently published guidelines relevant to their jurisdictions. 7, 8, 25 
